New research finds that cholesterol busting statins also reduce blood pressureMarch 09, 2007A new study led by researchers at Warwick Medical School at the University of Warwick reveals that patients using cholesterol busting statins get a bonus benefit from such drugs as the Warwick researchers have now found that statins also have a positive effect on blood pressure levels. The research, led by Professor Francesco Cappuccio at Warwick Medical School, examined 20 studies on the effects of statins that covered 828 patients. Of those 20 studies 291 patients were given statins, 272 were given a placebo and 265 were on crossover trials. Some of the studies looked specifically at hypertensive patients, the others considered a full range of conditions. The researchers found that the use of statins did produce a drop in blood pressure. The overall effect of the use of statins was a 1.9 mmHg reduction in systolic blood pressure and 0.9 mmHg in diastolic blood pressure. The effect was even more pronounced in patients with high blood pressure (systolic over 130 mmHg) who showed an average drop of 4.0 mmHg if treated with statins. This research clearly shows that treatment with statins produces a small but significant reduction in blood pressure. The effect is lower than the average effect of regular antihypertensive drugs. However this is an added bonus for patients already using statins to reduce cholesterol and the use of statins may reduce the dose and number of drugs a patient would require to keep their blood pressure at a satisfactory level.
The research has just been published in (Hypertension 2007, doi: 10.1161/ 01.HYP.0000259737.43916.42) in a paper titled "Do Statins Reduce Blood Pressure? A Meta-Analysis of Randomized, Controlled Trials " Note for editors: The research was led by Professor Francesco Cappuccio at Warwick Medical School. The other researchers were from the Federico II University Medical School in Naples, Italy and St George's Medical School at the University of London. University of Warwick | |||||||||||||||||||||
|
Related Statins Current Events and Statins News Articles Traditional Risk Assessment Tools Do Not Accurately Predict Coronary Heart Disease The Framingham and National Cholesterol Education Program tools, NCEP, do not accurately predict coronary heart disease, according to a study performed at the Yale University School of Medicine in New Haven, CT. Statin warning for pregnant women Pregnant women or those hoping to start or extend a family should avoid using the cholesterol-lowering drugs statins, say scientists. Study associates 11 new gene sites with cholesterol, triglyceride levels An international research team has identified 11 novel locations in the human genome where common variations appear to influence cholesterol or triglyceride levels, bringing the total number of lipid-associated genes to 30. New genes present drug targets for managing cholesterol and glucose levels Scientists have identified 12 new genes that are somewhat strange bedfellows: Some link gallstones and blood cholesterol levels, others link melatonin and sleep patterns to small increases in glucose levels and larger jumps in the risk of diabetes. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system. A scientific breakthrough on the control of the bad cholesterol A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor Bad cholesterol inhibits the breakdown of peripheral fat he so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis. Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes. MSU researcher studies ties between cholesterol drugs, muscle problems A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users. Researchers discover new risk factor for cardiovascular disease, and a way to control it A team of international researchers - including scientists from the McGill University Health Centre (MUHC) and McGill University - have discovered that having high levels of particular protein puts patients at increased risk of developing cardiovascular disease. More Statins Current Events and Statins News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||